KRAS and cancer: Meanwhile, Fig 3B depicts that downregulated DEGs were enriched in xenobiotic metabolism suggesting the hyperactive metabolism response of cancer cells, besides other metabolic pathways including myogenesis, coagulation and KRAS signaling.